{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:57:27Z","timestamp":1777568247903,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS \/16\/63\/32408"],"award-info":[{"award-number":["FS \/16\/63\/32408"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejphar.2024.176895","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T02:15:10Z","timestamp":1723688110000},"page":"176895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Is there a role for biogenic amine receptors in mediating \u03b2-phenylethylamine and RO5256390-induced vascular contraction?"],"prefix":"10.1016","volume":"981","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6906-9397","authenticated-orcid":false,"given":"Alexander C.","family":"Voisey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6490-8278","authenticated-orcid":false,"given":"Harrison D.","family":"Broadley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3339-2050","authenticated-orcid":false,"given":"Kenneth J.","family":"Broadley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8792-6169","authenticated-orcid":false,"given":"William R.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2024.176895_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1476-5381.1993.tb13534.x","article-title":"Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen","volume":"109","author":"Aboud","year":"1993","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.176895_bib2","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/j.1476-5381.2011.01706.x","article-title":"Vasoconstrictor and vasodilator responses to tryptamine of rat-isolated perfused mesentery: comparison with tyramine and beta-phenylethylamine","volume":"165","author":"Anwar","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176895_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.ejphar.2024.176895_bib5","article-title":"Dual excitatory and smooth muscle-relaxant effect of beta-phenylethylamine on gastric fundus strips in rats","author":"Batista-Lima","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"16","key":"10.1016\/j.ejphar.2024.176895_bib7","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1073\/pnas.151105198","article-title":"Trace amines: identification of a family of mammalian G protein-coupled receptors","volume":"98","author":"Borowsky","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"47","key":"10.1016\/j.ejphar.2024.176895_bib8","doi-asserted-by":"crossref","first-page":"20081","DOI":"10.1073\/pnas.0906522106","article-title":"The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system","volume":"106","author":"Bradaia","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejphar.2024.176895_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pharmthera.2009.11.005","article-title":"The vascular effects of trace amines and amphetamines","author":"Broadley","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2024.176895_bib10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejphar.2013.04.034","article-title":"Functional evaluation of the receptors mediating vasoconstriction of rat aorta by trace amines and amphetamines","volume":"715","author":"Broadley","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176895_bib11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","article-title":"Amphetamine, 3, 4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor","volume":"60","author":"Bunzow","year":"2001","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176895_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1113\/jphysiol.1958.sp006104","article-title":"The action of sympathomimetic amines in animals treated with reserpine","volume":"144","author":"Burn","year":"1958","journal-title":"The Journal of physiology"},{"issue":"11","key":"10.1016\/j.ejphar.2024.176895_bib14","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3390\/ph16111632","article-title":"Discovery of guanfacine as a novel TAAR1 agonist: a combination strategy through molecular modeling studies and biological assays","volume":"16","author":"Cichero","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176895_bib15","first-page":"631","article-title":"The lack of crossed tachyphylaxis between tyramine and some other indirectly acting sympathomimetic amines","volume":"30","author":"Day","year":"1967","journal-title":"Br. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.ejphar.2024.176895_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413185","article-title":"Therapeutic potential of TAAR1 agonists in schizophrenia: evidence from preclinical models and clinical studies","volume":"22","author":"Dedic","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176895_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00018-009-0174-4","article-title":"Subtypes of functional \u03b11-adrenoceptor","volume":"67","author":"Docherty","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176895_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00210-010-0554-1","article-title":"Identification of trace-amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by beta-phenylethylamine","volume":"382","author":"Fehler","year":"2010","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176895_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-201x.2000.00596.x","article-title":"Catecholamine biosynthesis and physiological regulation in neuroendocrine cells","volume":"168","author":"Flatmark","year":"2000","journal-title":"Acta Physiol. Scand."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2024.176895_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejphar.2013.10.003","article-title":"Identification and characterization of platelet \u03b12-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses","volume":"720","author":"Hikasa","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176895_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/BJ20090998","article-title":"Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands","volume":"424","author":"Hu","year":"2009","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176895_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-3565(25)27363-3","article-title":"A relatively nonspecific supersensitivity in aortic strips resulting from pretreatment with reserpine","volume":"153","author":"Hudgins","year":"1966","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176895_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.31887\/DCNS.2007.9.1\/jchuffman","article-title":"Neuropsychiatric consequences of cardiovascular medications","volume":"9","author":"Huffman","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176895_bib29","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1124\/mol.106.031773","article-title":"Alpha2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 region","volume":"71","author":"Jurgens","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176895_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46627-5","article-title":"Differential mechanisms of action of the trace amines octopamine, synephrine and tyramine on the porcine coronary and mesenteric artery","volume":"9","author":"Koh","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176895_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tips.2005.03.007","article-title":"A renaissance in trace amines inspired by a novel GPCR family","volume":"26","author":"Lindemann","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"15","key":"10.1016\/j.ejphar.2024.176895_bib36","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1111\/bph.15061","article-title":"TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking","volume":"177","author":"Liu","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176895_bib37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0022-3565(25)28830-9","article-title":"Species differences in aortic responses to vasoactive amines: the effects of compound 48\/80, cocaine, reserpine and 6-hydroxydopamine","volume":"176","author":"Maling","year":"1971","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176895_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/1043-6618(91)90035-V","article-title":"\u03b1-Adrenergic receptor subtypes on vascular smooth musculature","volume":"24","author":"Martinotti","year":"1991","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.176895_bib39","series-title":"Molecular Neurobiology of the Mammalian Brain","author":"McGeer","year":"2013"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176895_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2024.176895_bib44","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1177\/0271678X20943823","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"40","author":"Percie du Sert","year":"2020","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176895_bib46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/mp.2012.57","article-title":"A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic-and antidepressant-like activity, improve cognition and control body weight","volume":"18","author":"Revel","year":"2013","journal-title":"Mol. Psychiatr."},{"issue":"11","key":"10.1016\/j.ejphar.2024.176895_bib47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2012.05.014","article-title":"Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics","volume":"72","author":"Revel","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"20","key":"10.1016\/j.ejphar.2024.176895_bib48","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1073\/pnas.1103029108","article-title":"TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity","volume":"108","author":"Revel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176895_bib49","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0022-5347(25)00390-8","article-title":"Norepinephrine depletion and sensitivity changes in rat heart induced by pretreatment with reserpine","volume":"240","author":"Rice","year":"1987","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2024.176895_bib51","first-page":"91","article-title":"A guide to wire myography","volume":"108","author":"Spiers","year":"2005","journal-title":"Methods Mol. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176895_bib52","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bmcl.2010.12.075","article-title":"Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773)","volume":"21","author":"Stalder","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176895_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3565(25)33452-X","article-title":"Use of selective antagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta","volume":"224","author":"Stollak","year":"1983","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176895_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2148-10-51","article-title":"Functional evolution of the trace amine associated receptors in mammals and the loss of TAAR1 in dogs","volume":"10","author":"Vallender","year":"2010","journal-title":"BMC Evol. Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176895_bib56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.111.004697","article-title":"Serotonin and blood pressure regulation","volume":"64","author":"Watts","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176895_bib57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.106.112532","article-title":"Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1","volume":"320","author":"Wainscott","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924005843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924005843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:59:35Z","timestamp":1777402775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924005843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":39,"alternative-id":["S0014299924005843"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176895","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a role for biogenic amine receptors in mediating \u03b2-phenylethylamine and RO5256390-induced vascular contraction?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176895"}}